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334A ABSTRACTS- Myocardial Ischemia and Infarction 
There was no difference in the prevalence of thrombogenic disorders among the survi- 
vors of MI according to the presence of normal or diseased coronary arteries. 
Conclusions: there is a relatively high prevalence of hereditary thrombogenic disorders 
in pts who suffered a MI _<35 years, and this may contribute to the pathogenesis of MI in 
young pts. 
1193-45 Is Age Related to Platelet Activity in Patients Presenting 
With Acute Coronary Syndromes? 
Paul A. Gurbel, E. Magnus Ohman, Matthew T. Roe, Raymond D. Bahr, W. Brian Gibler, 
Victor L. Serebruany, for the EARLY Thai Investigators, Sinai Hosptial, Baltimore, 
Maryland, Duke University, Durham, North Carolina. 
BACKGROUND: Bleeding is a major risk of pharmacologic strategies to treat acute cor- 
onary syndromes (ACS) and is increased in the eldedy. This risk may be related to an 
age-dependent reduction in platalet activity.METHODS: Baseline platelet function and 
flow cytometry with menoclonal antibodies directed against multiple surface receptors 
were investigated in a substudy of the EARLY Trial (n=56) that treated patients present- 
ing to the Emergency Department with early or late (12-24 hours) eptifibatide.RESULTS: 
A significant negative correlation was observed between age and indicators of platelet 
activity. PAC-1 expression, a marker of Gp lib/Ilia activity, fell as age increased (r = - 
.5250) and platelet aggregation to 10H tool ADP was also lower in the elderly (r = -.5938, 
see figure). CONCLUSION: At presentation to the Emergency Department with acute 
coronary syndromes, older patients have less active platelets. The age-dependent 
increase in bleeding risk in the elderly may be related to reduced platelet activity as com- 
pared to younger patients. Monitodng of platelet function may lessen the bleeding risks in 
ACS treatment by appropriate adjustment of platelet inhibition. 
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1193-46 Sustained Reduction in Coagulation Activity During 
Long-Term Dalteparin Treatment in Unstable Coronary 
Artery Disease 
Jonas Oldaren. Edk Diderbolm, Eva Lindmark, Lars Wallentin, Agneta Siagbahn, Medical 
Sciences, Cardiology and Clin Chemist~ Uppsala, Sweden. 
Background: Short-term treatment with low molecular mass heparin is known to reduce 
coagulation activity. We have investigated the influence on markers of coagulation activ- 
ity by long-term treatment with dalteparin, a low molecular mass heparin, in patients with 
unstable coronary artery disease (CAD). 
Methods: Coagulation activity was monitored in 562 out of the 2267 patients with unsta- 
ble CAD in the Scandinavian multicenter study FRISC II. All patients were treated with 
subcutaneous dalteparin 120 IU/kg twice daily for 5-7 days and then randomised to pla- 
cebo (n=287) or long-term treatment with daltaparin (n=275) for 3 months. Women 
weighing < 80 kg, and men weighing < 70 kg, received daltaparin 5,000 IU twice daily 
and above these weight limits the daltaparin dose was 7,500 IU twice daily during long- 
term treatment. Prothrombin fragment 1+2 (F1+2) and D-dimer were analysed during in- 
hospital daltepadn treatment, during long-term daltaparin/placabo treatment at 6 weeks 
and 3 months, and at 6 months follow-up. Data are medians with Mann Whitney test. 
Results: See table 
Conclusion: There was a sustained reduction of coagulation activity, as indicated by 
lower levels of F1+2 and D-dimer, dudng long-term treatment with dalteparin as com- 
pared to placebo. A significantly higher coagulation activity was seen at follow-up 3 
months after termination of long-term daltaparin treatment, whereas coagulation activity 
was unchan~led at follow-up in the placebo group. 
F1+2, nmol/L D-dimer. microg/L 
daltepadn, 120 IU/kg p dalteparin, 120 IU/kg p 
In-hospital 0.79 0.78 0.8 30 31 0.5 
daltaparin placebo daltaparin placebo 
6 weeks 0.87 1.15 <0.001 20 43 <0.001 
3 months 0.86 1.10 <0.001 21 42 <0:001 
Post-treatment Post-treatment 
6 months 1.05 1.11 0.2 36 38 0.1 
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1193-47 Enhaoed Cort iso l  Secretion Does Not Control Aspirin- 
Insensitive Thromboxane Biosynthesis in Patients With 
Acute Coronary Syndromes 
Giulia Renda, Maria G. Sciulli, Francesca Seta, Stefania Tecconelli, Marta L. Capone, 
Antonio Rebuzzi, Paola Patrianani. "G. D'Annunzio" University of Chieti School of 
Medicine, Chieti, Italy, Catholic University School of Medicine, Rome,/ta/y 
We have explored 1) the involvement of monocyte COX-2 induction in enhanced throm- 
boxane (TX) A2 biosynthesis occurring episodically in patients with acute coronary syn- 
dromes treated with low-dose aspidn, and 2) the influence of endogenous cortisol 
secretion in TXA2 biosynthesis in this setting. Whole blood TXB2 and udnary 11-dehy- 
dro-TXB2 and cortisol levels were evaluated by RIA. In patients with acute myocardial 
infarction (AMI; n=15), unstable angina (UA; n=10) and chronic stable angina (CSA; 
n=15), the treatment with low-dose aspirin (160 mg/d) caused a similar suppression of 
platalet COX-1 activity while the biosynthesis of TXA2. in vivo, as reflected by the excre- 
tion of 11-dehydro-TXS2 in overnight udne samples, was significantly higher in patients 
with AMI and UA vs. SA [206±161 (p<O.01) and 126±86 (p<O.05) vs. 69±34 pg/mg crea- 
tinine, respectively]. The production of TXB2 in heparinized whole blood incubated for 4 h 
with bectedal endotoxin (LPS, 1 ~g/ml) was significantly (p<0.05) higher in patients with 
AMI vs. CSA but not vs. UA (52±29, 26.8±17 and 30±21 pg/lO 3 monocytes) and was pro- 
foundly suppressed (77-87%) by the selective COX-2 inhibitor L-745,337 (26 p.M). 
Plasma levels of C-reactive protein (CRP), a marker of systemic inflammation, were 
higher in patients with AMI and UA vs. those with CSA [40±43 (p<0.01) and 15±14 
(p<0.05) vs. 3.9±2.6 rag/I]. The urinary excretion of cortisol was significantly (p<0.01) 
higher in patients with AMI vs. those with UA and CSA [176±130, 58±57 and 46±52 ng/ 
mg creatinine]. Urinary cortisol correlated with 11-dehydro-TXB2 (r=0.516, n=36, 
p<0.01), LPS-induced TXB2 (r=0.552, n=20, p<0.05) and plasma CRP (r=0.408, n=36, 
p<0.05). Differently from patients with SA, in AMI and UA, the circadian rhythm of urinary 
cortisol excretion did not occur. In conclusion, COX-2 expression in circulating mono- 
cytes may participate in episodes of aspirin-insensitive TXA2 biosynthesis in acute coro- 
nary syndromes. Activation of the hypothalamic-pituitary-edrenal axis occurs in patients 
with acute coronary syndromes but it seems insufficient o control the inflammatory reac- 
tion presumably triggering aspirin-insensitive TXA2 biosynthesis in this setting. 
1193-48 Increased Homocysteine Levels Predict a More 
Complicated Course Following Acute Myocardial 
In farct ion 
Shlomi Matetzky. Dov Freimark, Sela Ben-Ami, Ilya Novikov, Michael Eldar, Hanoch Hod, 
Heart Institute Sheba Medical Center, Tel Hashomer, Israel 
Background: Although hyperhomocysteinema is associated with hypercoagulability and 
piatelet aggregation, and interferes with fibrinolysis, data are scarce regarding the effect 
of hyperhomocystaine levels on clinical outcome in patients with acute myocardial infarc- 
tion (AMI). 
Methods: Homocystaine was determined on admission in 160 consecutive patients with 
AMI by HPLC methodology with fluorescent detection. 
Results: Mean homocysteine levels in the entire group were 14±11 micromole/L. 
Homocysteine levels were higher in male (p<0.01) and non-diabetic patients (p<0.Ol), 
but were not associated with other risk factors or age (r=0.07, p=0.42). Patients (n=22) 
with homocysteine 320 micromole/L (34±9) compared with those of lower levels (n=135, 
10±4), had a lower incidence of diabetes mellitus (9% vs 28%, p=0.06). There was no 
significance difference regarding the in-hospital course and indices of infarct size, includ- 
ing peak CPK (p=0.7) and LVEF (p=0.45) in both groups of patients. Among the 112 
catheterized patients, those with homocysteine 320 and <20 micromol/L had a similar dis- 
tribution of the infarct-related artery, number of diseased coronary artedes (p=0.87) and 
prevalence of multi-vessel coronary artery disease (p=0.9). However, during mean fol- 
low-up of 30 months, the patients with higher homocysteine levels had a higher incidence 
of re-hospitalization for recurrent coronary events (38% vs 17%, p<0.O4) and a higher 
mortality rate (18% vs 5%, p<0.05). 
Conclusion: Elevated levels of homocystaine in AMI patients are associated with a higher 
incidence of recurrent coronary events and mortality. 
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1194-38 Pred ic tors  of  Emergency Coronary Artery Bypass 
Grafting in Percutaneous Coronary Interventions 
Niranjan Seshadri, Naveen Acharva. Penny Houghtaling, Eugene Blackstone, Stephen 
G. Ellis, Patrick L. Whitlow, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background and Aim: Advances in interventional cardiology have resulted in a 
decreased need for emergency coronary artery bypass grafting (EMCABG) following 
percutaneous coronary interventions (PCI). We sought to determine the current preva- 
lence and predictors of EMCABG. 
Methods: A retrospective review of all PCIs performed for a 4-year period between 1/2/ 
1997 and 12/29/2000 at our institution. Multivadable logistic regression modeling was 
performed to determine predictors of EMCABG. 
Results: There were 8830 PCI procedures performed (mean age 64± 12 yrs, 2575 F, 
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mean LVEF 52_+ 13%, 6485 stants) during the above period. There was a need for 
EMCABG in 29 (0.3%) patients (Indications-11 extensive dissection, 7 perforation/tam- 
ponade, 7 recurrent acute closure, 3 hemodynamic instability, 1 aortic dissection). In 
patients undergoing EMCABG, there were 6 (21%) in hospital deaths and 4 (14%) cere- 
brovascular accidents, in multivariate analysis, predictors of the need for EMCABG 
included female sex (odds ratio [OR], 2.5; 95% confidence interval [CI] 1.2 to 5.3; 
p=0.01 ) and a higher ACC scoring of the intervened lesion (OR, 1.7; 95% CI, 1.2 to 2.5; 
p=0.004). Patients with a prior bypass surgery were less likely to undergo EMCABG (OR, 
0.07; 95% CI, 0.01 to 0.6; p=0.01). 
Summery: The need for EMCABG following PCI has considerably decreased over the 
last decade and EMCABG is now rarely necessary. However, morbidity and mortality of 
EMCABG remain high. Risk factors for EMCABG following PCIs include female sex, a 
higher ACC score and no prior bypass surgery. 
11 94-39 The Effect of Off Pump Coronary Artery Bypass 
Procedures on Short- and Long-Term Survival 
Gerald M. Lawrie, Nan R. Earle, Elizabeth A. Earle, The Methodist Hospital, Houston, 
Texas, Baylor College of Medicine, Houston, Texas. 
Background: The value of off-pump CABs (OPCABs) remains controversial, We have uti- 
lized the procedure only in those groups of patients considered at high risk from cardio- 
pulmonary bypass: those with advanced age, cerebrovascular insufficiency, renal insuffi- 
ciency and Jehova's Witnesses. 
Methods: We prospectively followed a series of 1491 consecutive CAB patients from 
1993 to the present and compared survival outcomes using both logistic and Cox regres- 
sion analyses. Of these patients, 391 (22.1%) were selected for the OPCAB technique; 
the remainder underwent conventional CAB (CONCAB). 
Results: There were 105 females in the OPCAB group (31.9%) and 314 (27.0%) in the 
CONCABs (p=NS). OPCABs were older, 68.7±11.9, vs 64.7±10.3 yrs for CONCAB 
(p<0.0001). Number of bypass grafts were 2.4±0.8 and 2.9±0.9, respectively (p<0.0001). 
54.4% of OPCABs received ->1 internal mammary artery (IMA); 63.7 CONCABs received 
_>1 IMA (p=0.0057). 13.1% of the OPCABs were redo procedures; 12.7% of the CON- 
CABs were redo procedures (p=NS). 6.7% of OPCABs received concomitant coronary 
endarectomy (CND); 12.6% CONCABs had received concomitant CNDs (p=0.0029). 
Pedoperative mortality: 4.6% (15) for the OPCABs; 4.2% (49) for the CONCABs (p=NS). 
Significant predictors of perioperative mortality were age: relative risk (RR)=0.97; number 
of IMAs placed: RR=2.27. Significant predictors of late mortality: OPCAB: RR=I.6; age: 
RR=1.3; _>4 bypass grafts: RR=0.5; 1 IMA: RR=0.6; and concomitant CND: RR=2.0. 
Conclusion: The OPCAB procedure produced a comparable operative mortality in a 
group that was expected to have a significantly higher operative mortality. However, the 
OPCAB procedure was a significant independent predictor of increased Iong-tarm mor- 
tality, in addition to the effects of lower IMA usage and less complete revascularization. 
This study suggests the need for further evaluation of the effects of OPCAB on long-term 
survival. 
1194-40 Is the Gastroeplloic Artery Suitable for  Intermediate 
Coronary Artery Stenosis? 
Tsuvoshi Shimizu, Shigeki Ire, Katsusuke Iksda, Tetsuzo Hirayama, Shin Ishimaru, Akira 
Yamashina, Tokyo Medical Universi~ Tokyo, Japan. 
OBJECTIVES. The gastroepiploic artery (GEA) has been used as an in situ arterial graft 
for coronary revascularization. Although graft occlusion of the GEA due to flow competi- 
tion has been reported, it is still unclear whether the GEA is suitable for intermediate cor- 
onary artery stenosis. To elucidate this question, flow characteristics of the GEA were 
analyzed and compared with those of the aorto-coronary saphenous vein graft (SVG). 
METHODS. In 37 patents, 18 GEA grafts and 19 SVGs to the posterior descending 
artery or the postero-lateral branch were examined with a Doppler-tipped guide wire dur- 
ing coronary angiography after coronary artery bypass. Graft flow volume at rest and 
maximum graft flow volume during hyperemia were calculated from the grafl diameter 
and the average peak velocity at rest and the maximum average peek velocity induced 
by 10 mg of papaverine hydrochloride injection into the graft. The GEA grafts and the 
SVGs were classified according to the grade of native coronary artery stanosis; group M 
had more than 50% stenosis up to 75% stenosis and group S had more than 75% stano- 
sis. 
RESULTS. Group M-GEA, group S-GEA, group M-SVG and group S-SVG consisted of 
8, 10, 9 and t0 grafts respectively. Graft flow volume at rest was 16+/-8 ml/min in group 
M-GEA, 31+/-14 ml/min in group S-GEA, 27+/-11 ml/min in group M-SVG and 30+/-15 
m(/min in group S-SVG (M-GEA vs S-GEA or M-SVG: P<O.05), Maximum graft flow vol- 
ume was 37+/-15 ml/min in group M-GEA, 75+/-32 in group S-GEA, 81+/-30 in group M- 
SVG and 76+/-t7 ml/min in group S-SVG (M-GEA vs S-GEA or M-SVG: P<0.01). 
CONCLUSIONS. Due to flow competition, graft flow of the in situ GEA graft to the coro- 
nary artery with intermediate stenosis was less at rest and during hyperemia than that of 
the aorto-coronary SVG. Our data suggested that the GEA might be unsuitable for inter- 
mediate coronary artery stenosis. 
1194-41 Predictors of In-Hospital Mortality Among Older 
Diabetics Undergoing Coronary Artery Bypass Grafting: 
Results From the National Cardiovascular Network 
Emir Veledar. Elizabeth M Mahoney, Viola Vaccarino, Zefeng Zhang, Jovonne K. 
Williams, Jerome Abremson, William S. Weintraub, Emory University School of Medicine, 
Atlanta, Georgia. 
Background: Older diabetics undergoing CABG represent a high-risk group. Little is 
known regarding factors predicting in-hospital mortality in this patient subgroup. 
Methods: We studied 5,094 patients included in the National Cardiovascular Network 
(NCN) database who were aged 75 years or older, had a history of diabetes, and under- 
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went CABG between 1993-99. Nineteen pre-operative factors were considered in a logis- 
tic regression model. 
Results: Of the 5,094 patients, 373 (7.3%) died in the hospital. Age was 79±3 with 46% 
females, 31% heart failure, 11% renal insufficiency, 2% shock, 23% cerebrovascular dis- 
ease, 22% peripheral vascular disease, and 27% non-elective procedure. Ejection frac- 
tion was 47±13 and post-procedural length of stay was 10¢10 days. Logistic regression 
revealed 9 independent predictors of in-hospital mortality (p<0.05 for each factor; see 
table). The C-index for the model was 0.73 suggesting good predictive ability. 
Conclusions: We have developed a contemporary model that predicts CABG-relatad in- 
hospital mortality among older diabetics. As the number of older diabetics undergoing 
CABG is expected to increase, the risk stratification of these patients will become 
increasingly important for clinicians and researchers. 
Predictors of In-Hospital Mortality Among Older Diabetics Undergoing CABG 
Factor Odds Ratio (95% CI) P-Value 
Shock 4.49 (2.79-7.27) <0.001 
CABG+Valve 1.95 (1.46-2.57) <0.001 
Non-Elective Procedure 1.75 (1.37-2.23) <0.001 
Renal Insufficiency 1.62 (1.21-2.18) 0.001 
Cerebrovascular Disease 1.41 (1.09-1.83) 0.01 
Heart Failure 1.35 (1.04-1.75) 0.03 
Peripheral Vascular Disease 1.30 (1.01-1.68) 0.04 
Height (10 cm increase) 0.84 (0.76-0.94) 0.003 
1194-42 Do All Q Waves After Coronary Bypass Surgery Impact 
Six-month Prognosis? 
Bernard Chairman, Shunta Sakai, Faisal Hasan, Jeffrey Gavard, Karen Stocks, Pierre 
Theroux, Guardian Investigators, SL Louis Universi~ SL Louis, Missouri, Montreal Heart 
Institute, Montreal, Canada. 
Background: The prognostic significance of new postoperative Q waves after coronary 
bypass surgery (CABG) is controversial. 
Methods: We examined 2332 pts that underwent CABG in the Guardian trial and had 
routine postoperative CK-MB and ECG measurements and 6-month follow-up. 
Results: The 6-month mortality rate was 10.9% (12/110) vs 4.8% (107/2222) in pts with 
and without postoperative Q waves (p<0,01), Frequency of new postoperative Q waves 
(QMI) increased with increasing levels of postoperative CK-MB release (p<0.001). Of the 
110 pts with new OMI, there were no associations with cardiac enzyme elevation and 
gender, new right bundle branch block, new isolated ST elevation (STE) or ST depres- 
sion (STD), Q wave location, number of Q waves, or persistence of Q waves >4 wks after 
CABG. When the 38, 34 and 38 QMI pts with CK-MB >5 and <20, and ->20 ULN were 
examined, new postoperative STE with reciprocal STD occurred in 3%, 26% and 26% of 
pts (p<0.01); 6-month mortality rate was 25% (5/20) vs 7.8% (7/90) in pts with vs without 
the ST segment changes (p<0.05). Among the 848 pts with CK-MB ->5 ULN, the 6-month 
mortality rates were 15.3% in 72 pts with QMI vs 8% in 776 pts without QMI (p=0.03). 
Conclusion: All new postoperative Q waves do not increase the short-term mortality risk 
after CABG. The risk is significantly increased when classic STE occurs in Q wave leads 
and reciprocal STD is present or when CK-MB release exceeds 5ULN. Our findings sup- 
port the recent ACC/ESC consensus document on redefinition of MI. 
ULN=CK-MB upper limit of normal for the laboratory 
CK-MB N 6-month Mortality New QMI Incidence 
<6 ULN 1484 3.1% 2.6% 
->5 and <20 ULN 688 6.3% 4.9% 
->20 ULN 160 18.8% 23.8% 
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870-1 The National Registry of Cardiopulmonary 
Resuscitation: A Preliminary Report of 5,030 Adult In- 
Hospital Cardiac Arrests 
William Kaye, Vinay Nadkarni, Mary E. Mancini, Wayne Copes, Scott Carey, Joseph P. 
Ornato, Tanya Lane Truitt, Mary Ann Peberdv. for the NRCPR Investigators, American 
Heart Association, Dallas, Texas. 
Background: Survival from in-hospital adult cardiac arrest (CA) shows little improve- 
ment over time. The National Registry of CardioPulmonary Resuscitation (NRCPR) was 
established in 1999 to collect and analyze data on hospital CA. NRCPR analysis can 
identify event factors associated with survival from in-hospital CA. Methods: 5,030 adult 
(age >18) index CA events requiring compressions and/or defibrillation were analyzed 
from 108 hospitals using standard Utstein operational definitions of event variables and 
outcomes. (Chi.square, Welch's 2-sample t-test). Results: Overall survival to discharge 
(S) was 16.4% (626/5,030). Survival to discharge for CA with pulse requiring compres- 
sion was 24.2% (44/182) vs 16.1% (782/4,848) for pulseless CA (p<0.01). 85% of all CA 
were monitored and/or wittnessed (M/W). Of 2,232 ICU CAs, 98.4% were M/W; S = 
